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Summary.-In mice given a single dose of diethylnitrosamine, a hepatonecrotic
dose of carbon tetrachloride, 5 weeks after dosing with DEN and repeated 6 times at
4-weekly intervals, augmented the tumour yield in the livers. A single hepatonecrotic
dose of CC14 24 h before a single dose of DEN also increased the number of tumours
produced. The effect of the repeated administration of CC14 after the dose of DEN
occurred in addition to, and was therefore independent of, the enhancing effect of a
single dose of CC14 before DEN.
These results may be interpreted as implying (1) that the liver in the regenerative
phase after a hepatonecrotic dose of CC14 is more susceptible to an initiating action
of DEN, i.e. produces more potential foci of tumour growth than in the normal liver
and (2) that the repeated doses of CC14 leading to repeated phases of regeneration,
after the dose of DEN, provide a promoting stimulus.
THlE number oftumours produced in the
liver of animals given a dose of diethyl-
nitrosamine (DEN) is increased if they
are previously subjected to partial hepa-
tectomy (Griinthal et al., 1970) or treated
with a hepatonecrotic dose ofCC14 (Pound,
1978). The variation of the tumour yield
with the interval between the two treat-
ments has led to the opinion that the liver
is more susceptible to the carcinogenic
action when the cells are proliferating
rapidly in the regenerative phase, although
a particular susceptible phase of the cell
cycle has not been demonstrated. Factors
affecting the metabolic activation of the
carcinogens complicate the issue (Pound
and Lawson, 1975). A similar suscepti-
bility of proliferating tissue is shared by
other nitrosamines (Craddock, 1975;
Pound, 1978) and other carcinogens.
Since tumours do not appear until some
time after giving the carcinogen, that
persists in the tissues only for a short time
after a single injection, the interpretations
have been advanced that (1) a proportion
of the cells of the liver is altered in some
way such that they may develop into
tumours, and (2) this proportion is in-
creased when the carcinogen is given to a
proliferating tissue. The question therefore
arises whether conditions exist that stimu-
late such latent cells to develop into
tumours either more rapidly or in greater
number, such as are provided by the
promoting agent croton oil in the classical
two-stage mechanism developed as a
hypothesis primarily to elucidate carcino-
genesis in the mouse skin.
Marginal increases in the yields of
hepatocellular tumours due to ionizing
irradiation have been reported by the
action of a hepatonecrotic dose of CC14 up
to 9 months later (Cole and Nowell, 1965;
Curtis, Czernik and Tilley, 1968) and by
partial hepatectomy after a dose of X-
irradiation (Haran-Ghera et al., 1962).
Similar results have been found in rats
subjected to 3 partial hepatectomies at
5-week intervals starting 5 weeks after a
dose of DEN a relatively poor liver
carcinogen in this animal-and grounds
discussed for regarding even a marginal
increase under these conditions as signifi-
cant (Pound and McGuire, 1978).A. W. POUND AND L. J. MCGUIRE
This paper reports the effect ofrepeated
doses of CC14 at 5-week intervals, starting
5 weeks after a dose of DEN, to normal
mice or to mice treated 24 h previously
with a dose of CC14.
AIATERIALS AND METHODS
Animals. Random-bred male Quacken-
bush mice, about 30 g wreight and on average
6-7 weeks of age, were obtained from the
Central Animal Breeding House, University
of Queensland. They were maintained on a
pelleted high-protein (200o) diet wAith an
adequate mineral and vitamin supplement
obtained from Bunge Ltd., Australia. The
diet and water wNere freely available. The
animals MNere housed in tins of6, wN-ith sawdust
bedding changed wieekly.
Chemicals.-Diethylnitrosamine (purest
grade), DEN, was obtained from Fluka A.G.
Chemische Fabrike, Switzerland. Carbon
tetrachloride A.R., CC14, was obtained from
Ajax Chemical Co., Auburn, N.S.W. DEN
was administered by i.p. injection of 0-2 ml
of a solution in 0-9%o saline, and CC14 was
given by i.p. injection in 0 4 ml olive oil.
Histological methods. Tissues were fixed
in 40o formalin in 0-9%o saline, pH 7-2, phos-
phate-buffered, and processed by routine
paraffin-embedding methods. Sections were
cut at 5 jtm and stained wA,ith haematoxylin
and eosin (HE). PAS stain was used to
identify glycogen.
Experimental. Mice were selected at ran-
dom to form 6 groups as follows: Group 1, 45
mice were given a dose of 0-25 ml CC14/kg fol-
lowAed 24h later by a dose of80 mg DEN/kg; 5
weeks later they wiere given a dose of 0-25 ml
CCl4/kg and the dose of CC14 w%as repeated 6
times at intervals of 5 w^reeks; Group 2, 35
mice were given an i.p. injection of 80 mg
DEN/kg followed 5 weeks later by 7 repeated
injections of 0-25 ml CC14/kg at 5-week inter-
vals as in Group 1; Group 3, 35 mice were
given a dose of 0-25 ml CC14/kg followed 24 h
later by a dose of 80 mg DEN/kg and no
further treatment; Group 4, 35 mice were
dosed with 80 mg DEN/kg and had no further
treatment; Group 5, 50 mice received 7
injections of 0-25 ml CC14/kg at 5-week inter-
vals; Group 6, 45 mice had a single injection
of 0-25 ml CC14/kg only. After 12 months the
surviving animals were killed and the livers
and kidneys removed for examination.
Six identically treated groups of inice were
randomly constituted at the same time and
used to provide specimens of livers after
20 weeks (i.e. just before the 4th injection of
CC14 was due) and after 35 weeks (i.e. just
before the 7th injection of CC14 was due), at
which times 5 animals of each ofthese groups
-were killed and the livers removed for ex-
amination.
Livers were examined by cutting into thin
slices. The numbers of tumours and "wvhite
spots" (focal proliferations presenting on the
surface (see below)) was counted. The mean
diameter of tumours was measured. The
number of cystic lesions (cholangiomata) and
the size of these lesions was also determined.
Sections of the livers were systematically
scanned for the presence of focal prolifera-
tions, and the number recorded as the number
per cm2 of section (Pound, 1978). Sections of
the livers from the 20- and 35-week specimens
were similarly scanned but (for technical
reasons) only areas of0 5 cm2 were examined,
so the figures are not comparable with those
of the autopsy specimens.
RESULTS
The animals of all groups remained in
reasonable condition, although those
treated with DEN appeared to be smaller
than those in the control CCl4-treated
groups. Animal weights at autopsy varied
considerably within the groups, so that
the apparent difference in size was not
statistically significant, and, in any event,
is of no value since in some animals
tumours were up to 3 cm or more in
diameter. Livers appeared to be about
normal size when the presence of tumours
did not interfere with assessment. The
death rates in DEN-treated mice and
especially in the DEN-multiple CC14-
treated groups were somewhat greater
than in the other groups, but the differ-
ences were not significantly different; the
dead animals in later stages had a high
incidence of large and multiple tumours
of the liver in the former groups.
Histological examination of the liver
(apart from proliferative lesions of the
hepatocytes and bile ducts) showed no
relevant structural abnormality at any
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TABLE I.-Hepatocellular Tumours and Cholangiomas in the Livers and Tumours in
the Kidneys of Mice Subjected to Necropsy 52 weeks after Treatment with DENV
Liver tumours
CCl4
before
Group DEN*
I +
2 _
3 +
4 _
+
6
Treatment
_
CC14
x 7
after No. of
DENt I)ENt mice
I- + 28
26
4+ - 26
+ - 29
- - 40
- +- 38
Hepatocellular
tumours
No. of No. of
mice tumours
28 172
21 46
20 79
14 26
Cholangiomas
r-
No. of No. of
mice tumouirs
12 24
6 7
9 16
3 6
No. of
mice
writh
both
ttumoturs
12
2
8
2
Kidney tuimours
r
No. of N'o. of
mice ttimours
2 2
2 .3
3 5
* Single dose 0-25 ml CCI4/kg i.p.
t Single( dose 80 mg DEN/kg i.p.
1 7 x 0-25 ml CCl4/kg, 5-week intervals, Ist 5 weeks after DEN.
stage. In particular, there was no evidence
of fibrosis or cirrhosis. The doses of CC14
used (0-25 ml/kg) would produce necrosis
of between 40 and 7000 of the liver in the
centrilobular zones so that after 7 doses a
considerable degree of hyperplasia must
have occurred. The livers from animals
sampled at 20 and 35 weeks showed some
degree of accumulation of glycogen in the
hepatocytes, indicating some functional
disturbance under these treatments.
No tumours were found in the livers or
kidneys of the animals of Group 5 given
multiple injections of CC14, nor in the
animals ofGroup 6 given a single injection.
Secondary embolic tumours were seen in
one kidney, but resembled the pulmonary
"adenomas" in the animal rather than
any area of the large hepatocellular
tumours present in the same animal. The
number of tumours and other lesions in
the liver and kidneys ofthe mice surviving
52 weeks is set out in Table I. Occasional
tuLmours in the lungs and other sites are
not considered. The relevant lesions in the
liver comprised hepatocellular tumours,
focal proliferations, lesions termed "white
spots", and cystic lesions of bile-duct
origin.
Kidney tumours
A small number of tumours was seen in
the kidneys at necropsy. These were
papillary adenomas or adenocarcinomas
ofa type described elsewhere (Pound et al.,
1973; Pound, 1978). The number of these
lesions in mice given CC14 before DEN was
greater than in mice given DEN without
prior treatment, not significantly so (X2
1-5, 1 d.f., 0-1>P>0 05), but consistent
with previous findings in rats (Pound et al.,
1.973) and mice (Pound, 1978). On the
other hand, injections of CC14 after DEN
had no influence on the yield ofthe kidney
tumours. In addition, the kidneys showed
a number of "papillary cysts" (Pound
et al., 1973; Pound, 1978; McGiven and
Ireton, 1972). These lesions are not con-
sidered further.
Hepatocellular lesions
The lesions classified as hepatocellular
tumours and focal proliferations have
been described briefly in the rat (Pound
et al., 1973; Pound and McGuire, 1978)
and in the mouse (Pound, 1978). They
fall into 3 types according to the cells
comprising them; clear cell, liver cell and
dark cell. In the rat the clear-cell type is
the most frequent and the dark-cell type
the least, whereas in the mouse the liver-
cell and dark-cell types are the most
frequent. Focal proliferations in the mouse
invade veins (Pound, 1978) in about 25%
of cases, but systemic metastatic lesions
have not been seen. The lesions referred
to as "white spots" are focal proliferations
that can be seen on the surface. In many
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of the mice the hepatocellular tumours
were very large, and sometimes formed
confluent masses throughout the liver.
The relative proportions of the different
types did not vary between the groups.
Cholangiomas
These lesions consisted of multilocular
cysts, sometimes with few, at other times
with many loculi containing thin fluid and
lined by cuboidal epithelium resembling
that of the bile ducts. They varied in size
from -'3 mm to 35 mm diameter. They
were seen only in animals 35 weeks or
more after the dose ofDEN, and therefore
appear to develop at a slower rate than
hepatocellular tumours. They were fre-
quently accompanied by small foci ofbile-
duct proliferation, as has been noted in
rats given dimethylnitrosamine (Pound
et al., 1973). Having once appeared they
seem to enlarge and grow progressively,
and hence areregarded as neoplastic. They
are referred to as cholangiomas or chol-
angiomatous cysts.
Distribution of liver tumours
The proportion of animals with hepato-
cellular tumours (Table I) varied between
the groups. Ranked in order, in Group 1
100%, in Groups 2 and 3 -80% and in
Group 4 -.d50% of the animals had
tumours. This ranking follows the inci-
dence oftumours in the surviving animals,
TABLE II.-Numbers and Size of Hepatocellular Tumours and Numbers of White Spots,*
in Mice subjected to Necropsy 52 Weeks after Treatment with DEN
Diam. of hepatocellular tumours
(mm)
No.of -- No.of
Group mice >32 >16 >8 >4 >2 tumours
28
26
26
29
3 22 45
2 0 5
11 21
1 2 5
42
11
17
13
60
28
30
5
172
46
79
26
No. of
"white
spots"
268
77
59
15
* "White spots" is a descriptive term for focal proliferations visible on the surface with the naked eye.
TABLE III.-Incidence and Size ofFocal Proliferations at Different Times after
Treatment with DEN
Duration
of
experiment
Group (wks)
52
1 35
20
52
2 35
20
52
3 35
20
52
4 35
20
No. mice
in
sample
28
14
6
26
12
5
26
12
5
29
12
6
Mice with focal proliferations--5~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
No. mice No. lesions*
28
11
4
26
4
1
22
8
1
15
0
0
Diam. of lesions
(mm)t
9 3±3-4 0-96 (0-20-1-5)
2-71 0-71 (0-07-1-2)
1-67 0 34 (0-10-0-96)
3-5±2-3 0 74 (0-2-1-3)
(5): 0-51 (0-15-1-19)
(2) 0-22, 0 55
4-1±2-2 0-63 (0-2-1-3)
(12) 0-56 (0-14-1-2)
(2) 050, 0-22
1-2±2-4 0-46 (0 2-1 0)
Mice with tumours
No.
No. mice tumours
28 172
9 19
21 46
1 1
20 79
3 3
14 26
1 1
* Number of focal proliferations per cm2 scanned in mice of all samples.
t Mean (range), otherwise actual diameters.
I Numbers in brackets are the actual numbers of lesions counted in these groups, in total of 6 and
3 cm2 respectively for the 12- and 5-mouse samples.
1
2
3
4
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which varies significantly between the
groups (X2=150, 3d.f., P<0 001). Pre-
liminary treatment with CC14 increased
the yield of tumours (Group 3 vs Group 4,
x2- 33, 1 d.f., P<0 001). Multiple injec-
tions of CC14 after DEN increased the
yield of tumours in mice given no pre-
liminary CC14 (Group 2 vs Group 4, x2
8X0, 1 d.f., P<005) and also in mice given
such preliminary treatment (Group 1 vs
Group 3, x2 28-0, 1 d.f., P<0001). A
single dose of CC14 before DEN increased
the tumour yield more than multiple
injections after dosing with DEN to
previously untreated animals (Group 2 vs
Group 3, X2! 5X1, 1 d.f., P<0*025).
The number of "white spots" also varies
significantly between groups (Table II).
Histologically, "white spots" are focal
proliferations that appear on the surface
and provide an index of the incidence of
the lesions as indicated by comparing the
counts of "white spots" with the estimates
of the numbers of focal proliferations
obtained by scanning sections (Table III).
Preliminary treatment with CC14 increased
the yield of white spots (Group 3 vs Group
4 x2 3123, 1 d.f., P<0001). Multiple
injections of CC14 increased the yield in
previously untreated mice given DEN
(Group 2 vs Group 4, x2 49, 1 d.f., P<
0 001) and in mice previously treated with
CC14 (Group 1 vs Group 3, x2 118, 1 d.f.,
P<0u001). It is of interest that, in the
groups given CC14 before dosing with
DEN, the yield of white spots (268) in
Group 1, that had subsequent repeated
doses of CC14, is greater (x2 25, 1 d.f.,
P<0*001) than would be expected (1-28)
from the tumour yields in the animals of
Group 3 if the white spots were supposed
to increase in the same proportion as the
tumours. Similarly, in the groups that had
no preliminary CC14, the yield of white
spots in Group 2 (77) after repeated doses
of CC14 is greater (X2
= 27, 1 d.f., P<
0.001) than to be expected (27) from the
results of the tumour yields in the animals
ofGroup 4, on the same basis. This finding
is reflected in the figures of Table II that
show that this index of the incidence of
these lesions is greater than the number of
tumours in Groups 1 and 2 (e.g. in animals
given multiple injections of CC14 after
dosing with DEN); while in the animals of
Groups 3 and 4, that did not have this
treatment, this index of the incidence of
focal proliferations is less than the number
of tumours.
With a view to obtaining preliminary
data on the time of appearance of the
lesions, sections of livers taken at 20 and
35 weeks after dosing with DEN, and at
necropsy, were scanned for focal prolifera-
tions, and the number of tumours present
noted (Table III). Focal proliferations are
recorded as the number seen per cm2 (over
all the mice in the sample) except where
the numbers are too small and are then
recorded as the actual numbers seen.
Although focal proliferations in Groups 1,
2 and 3 appear by the 20th week, and
tumours by the 35th week (perhaps
earlier than in Group 4), these results do
not signify a very great difference in the
time ofappearance ofthe first lesionssince,
for statistical reasons, if more lesions
develop some are likely to be seen earlier.
The larger mean size (Table III) of the
lesions in Groups 1 and 2 perhaps suggests
that the lesions grow more rapidly in these
groups, which would make them more
readily observed, as well as suggesting
that they have been present for a longer
time (i.e. appeared earlier).
The number of focal proliferations in
the groups varies with the number of
tumours, as found previously in rats
(Pound et al., 1973) and mice (Pound,
1978).
Distribution of cholangiomatous cysts
The ranking order of animals with
cholangiomatous cysts (Table I) follows
a different pattern to that of hepato-
cellular tumours and focal proliferations.
Groups 1 and 3, given a preliminary dose
ofCC14, had a higher proportion ofanimals
with cholangiomas and a higher incidence
of the lesions in the surviving mice than
found in Groups 2 and 4 that had no such
preliminary treatment (Grouips 2 and 4
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vs Groups 1 and 3: for proportion of
animals x2=48, 1 d.f., P<0-025; for
incidence of tumours x2 13X9, I d.f.,
P<0 001). Comparing Groups 2 and 4,
repeated doses of CC14 in animals given
DEN alone obviously had no effect on the
incidence of these growths and, comparing
Groups 1 and 3, the increased yield pro-
duced by repeated doses ofCC14 in animals
given DEN after a preliminary injection
of CC14 is not statistically significant
(x2 ]1, 1 d.f., N.S.).
DISCU,SSION
The increase in the number of hepato-
cellular tumours produced in animals by a
variety of nitrosamines, given when the
liver is regenerating actively after a
hepatonecrotic dose of CC14, has been
reported (Pound, 1978) and is confirmed
by the present data with DEN in younger
mice. The number of cholangiomatous
cysts also increased, and perhaps this may
be associated with proliferative processes
in the liver. AIn increase in the yield of
kidney tumours (Pound et al., 1973;
Pound, 1978), and depression of the
activity of microsomal enzymes in re-
generating livers following partial surgical
or chemical ablation (Barker et al., 1969;
Henderson and Kersten, 1971), in particu-
lar of enzymes concerned in metabolism
ofnitrosamines (Pound and Lawson, 1975),
suggests that metabolic factors may also
play a role. Notwithstanding details of the
biochemical mechanisms of action, it is
evident that some of the liver cells are
altered in such a way that some of them
subsequently develop into tumours, and
that the proportion of dormant tumour
cells is increased when the carcinogen is
administered to an animal in which the
liver is regenerating after partial ablation.
When the dose of DEN was followed
5 weeks later by 7 doses of CC14 at 5-week
intervals, the number of hepatocellular
tumours that developed was greatly in-
creased. The increase occurred in alnimals
that had no preliminary treatment, as
wNell as in animals that had a preliminary
hepatonecrotic dose of CC14. In animals
given both the preliminary treatment and
the repeated doses of CC14 after DEN, the
increase was greater than if the effects of
the preliminary treatment and the sub-
sequent repeated dose in separate experi-
ments were added (172 vs 125, x2,-881,
1 d.f., P<0 05). It is obvious that the
number of postulated dormant tumour
cells is much larger than eventually
appears as tumours, and represents a more
or less permanent change. A reasonable
interpretation is that the repeated doses
of CC14 enhance the probability that they
will proliferate to become tumours. The
same conclusions follow from a study of
the focal proliferations, which appear to
be tumours in an early stage of develop-
ment. Repeated doses of CC14 therefore
appear to act in an analogous role to that
of a promoting agent in the "two stage"
hypothesis for a mechanism of carcino-
genesis (Berenblum and Shubik, 1947;
Salaman and Roe, 1964).
The finding that the yield of focal
proliferations is greater in the groups
treated with multiple injections of CC14
after dosing with DEN than would be
expected from the increase in the number
of tumours suggests that further groups of
dormant cells continue to be brought into
a proliferative phase, rather than that this
results from acceleration of the rates of
growth. The growth kinetics of focal pro-
liferations need to be investigated. If the
altered cells divided at a similar rate to
normal liver cells and were subject to the
same stimulus to proliferate, localized
focal accumulations could develop only
very slowly. No definitive evidence re-
lating to rates ofgrowth of the lesions was
obtained from these experiments.
The hyperplastic response in the liver
after 7 doses of CC14 is very great. The
dose used produces centrilobular necrosis
of about 40%O of the liver in 7-week-old
mice, increasing with age to about 7000
in 30-week-old mice. Regenerative hyper-
plasia restores the liver mass in about 7
days. After 7 doses the liver may be con-
sidered to be derived from about 1/200 of
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the original liver mass, and each cell could
have divided 8 or more times. Moreover it
would have been derived from the peri-
pheral parts ofthe liver lobules that escape
the hepatonecrotic effect of CC14 and dis-
play the least cytological damage by
nitrosamines. However, a dose of DEN
sharply inhibited DNA synthesis in the
regenerating zone and damage to DNA is
likely (Pound, unpublished data). The
proliferative response in the bile duct areas
is rather less, although significant, and
appears to occur at a slower pace. This
perhaps is related to the insignificant
effect of multiple doses of CC14 on the
yield of bile-duct tumours.
The question arises whether the in-
creased hepatocellular tumour yield is
related solely to the vigorous hyper-
plastic response. CC14 itself has a carcino-
genic action (Eschenbrenner, 1944), par-
ticularly in some strains of mice, but the
tumours develop only after a long time
and very many repeated doses. CC14 can
therefore only be a weak carcinogen.
Neither tumours nor focal proliferations
have been produced by the repeated doses
of CC14, which are large for a chemical
carcinogen, in our mice. On the contrary,
the reported weak carcinogenic effect of
CC14 may be due to a promoting action
with an initiating agent provided by a
minor carcinogen in the diet, or even by
CC14 itself.
Evidence that the carcinogenic response
to DEN in rats, as assessed by the occur-
rence of focal proliferations and tumours,
is increased by three partial hepatectomies
at 5-week intervals and starting 5 weeks
after dosing with DEN has been reported
(Pound and McGuire, 1978). Problems of
interpretation arise in this type of experi-
ment and, although the increase was small,
reasons were put forward to regard it as
biologically significant. In earlier reports,
3 small partial hepatectomies after a
carcinogenic treatment with X-irradiation
marginally increased the tumour yield
(Haran-Ghera et al., 1962). A single partial
hepatectomy during a course of feeding
acetylaminofluorene (Laws, 1959) or di-
39
methylaminoazobenzene (Glinos, 1964)
accelerated the yield of tumours, but only
marginally increased their number. A dose
of CC14 after a single carcinogenic dose of
X-irradiation (Cole and Nowell, 1965) and
up to 9 months after X-irradiation or
neutron bombardment (Curtis et al., 1968)
marginally increased tumour yields. The
single phase ofregenerative hyperplasia in
these reported experiments is a good deal
less vigorous than that produced by our
3 successive partial hepatectomies, when
regeneration occurred from about 1/6 of
the original liver (Pound and McGuire,
1978) and is very much less than occurs
after 7 doses of CC14. If the yield of
tumours increased linearly with the num-
ber of doses of CC14, a statistically signifi-
cant increase could be expected after
between 2 and 3 doses (implying regenera-
tion from about 1/8 of the original liver
mass); this implies a slightly greater
hyperplastic response than occurred in the
3 partial hepatectomy experiment. It is
therefore possible to assume that the
increases caused by partial hepatectomy
or by CC14 are not quantitatively incon-
sistent with each other or with the view
that the proliferative response is the
significant factor. A rigorously designed
comparison of the actions of CC14 and
partial hepatectomies in this regard is
likely to provide important information.
In the case ofpromotion in skin carcino-
genesis in mice, not all agents that lead to
hyperplasia are in fact promoting agents,
although the converse is invariably true
(Boutwell, 1974). The two observations
are not necessarily in conflict, but the
difference may hinge around the cellular
mechanisms by which the agent stimu-
lates the hyperplastic response. In the
case of CC14, the cytological damage is
largely due to an attack on endoplasmic
cell membranes (Pound, unpublished) and
it is of some interest that this may be a
point of attack of the phorbol esters which
are active agents in the promoting agent,
croton oil (Boutwell, 1974). Recent data
suggest that administration of phorbol to
mice dosed with dimethylnitrosamine pro-
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motes tumour formation in the liver and
lungs (Armuth and Berenblum, 1972). It
would be ofgreat significance to determine
the effect ofthis chemical on the liver and
other tissues.
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